Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 8, 2014, Pages 1285-1291

  Mahal, Brandon A ^a   Ziehr, David R ^a   Aizer, Ayal A ^b   Hyatt, Andrew S ^a   Sammon, Jesse D ^c   Schmid, Marianne ^a   Choueiri, Toni K ^a   Hu, Jim C ^d   Sweeney, Christopher J ^a   Beard, Clair J ^a   D'Amico, Anthony V ^a   Martin, Neil E ^a   Lathan, Christopher ^a   Kim, Simon P ^e   Trinh, Quoc Dien ^a   Nguyen, Paul L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d UCLA MEDICAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Affordable Care Act; African American; Cancer; Disparities; Insurance; Prostatic neoplasm

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BRACHYTHERAPY; CANCER REGISTRY; CANCER RISK; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HEALTH CARE DISPARITY; HEALTH INSURANCE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNINSURED; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACISM; RISK ASSESSMENT; CAUCASIAN; ECONOMICS; ETHNOLOGY; HEALTH CARE POLICY; INSURANCE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTHCARE DISPARITIES; HUMANS; INSURANCE COVERAGE; MALE; MIDDLE AGED; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PROSTATIC NEOPLASMS; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84922640123     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.04.014     Document Type: Article

References (30)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29.
2. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. J Am Med Assoc 1997, 277:1445-1451.
3. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. J Am Med Assoc 1998, 280:969-974.
4. NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer. Available at: 2014 [accessed 30.12.2013]. http://www.nccn.org.
5. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011, 364:1708-1717.
6. Wilt T.J., Brawer M.K., Jones K.M., et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012, 367:203-213.
7. Warde P., Mason M., Ding K., et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011, 378:2104-2111.
8. Widmark A., Klepp O., Solberg A., et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009, 373:301-308.
9. D'Amico A.V., Chen M.H., Renshaw A.A., Loffredo M., Kantoff P.W. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. J Am Med Assoc 2008, 299:289-295.
10. Jones C.U., Hunt D., McGowan D.G., et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med 2011, 365:107-118.
11. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD. based on November 2012 SEER data submission, posted to the SEER web site; April 2013. http://seer.cancer.gov/csr/1975_2010/.
12. Taksler G.B., Keating N.L., Cutler D.M. Explaining racial differences in prostate cancer mortality. Cancer 2012, 118:4280-4289.
13. Barocas D.A., Grubb R., Black A., et al. Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer 2013, 119:2223-2229.
14. Bigler S.A., Pound C.R., Zhou X. A retrospective study on pathologic features and racial disparities in prostate cancer. Prostate Cancer 2011, 2011:239460.
15. Underwood W., Jackson J., Wei J.T., et al. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer 2005, 103:538-545.
16. Sundi D., Ross A.E., Humphreys E.B., et al. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?. J Clin Oncol 2013, 31:2991-2997.
17. Patient Protection and Affordable Care Act, 42 U.S.C. § 18001 et seq; 2010.
18. Surveillance, Epidemiology, and End Results (SEER) Program: Research Data (1973-2010), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, based on November 2012 SEER data submission, posted to the SEER web site; April 2013. http://www.seer.cancer.gov/.
19. United States Census Bureau. Census. Gateway [online database]. Available at: 2000 [accessed 27.12.2013]. http://www.census.gov/main/www/cen2000html.
20. United States Department of Agriculture Rural-Urban Continuum Codes [online database]. Available at: [accessed 27.12.2013]. http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx.
21. Fine J., Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
22. Sommers B.D., Bindman A.B. New physicians, the Affordable Care Act, and the changing practice of medicine. J Am Med Assoc 2012, 307:1697-1698.
23. Stokes W.A., Hendrix L.H., Royce T.J., et al. Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study. Cancer 2013, 119:2486-2493.
24. Hasan O., Orav E.J., Hicks L.S. Insurance status and hospital care for myocardial infarction, stroke, and pneumonia. J Hosp Med 2010, 5:452-459.
25. Shen J.J., Washington E.L. Disparities in outcomes among patients with stroke associated with insurance status. Stroke 2007, 38:1010-1016.
26. Trinh Q.D., Schmitges J., Sun M., et al. Morbidity and mortality of radical prostatectomy differs by insurance status. Cancer 2012, 118:1803-1810.
27. Loehrer A.P., Song Z., Auchincloss H.G., Hutter M.M. Massachusetts health care reform and reduced racial disparities in minimally invasive surgery. JAMA Surg 2013, 148:1116-1122.
28. Pollack C.E., Bekelman J.E., Epstein A.J., Liao K., Wong Y.N., Armstrong K. Racial disparities in changing to a high-volume urologist among men with localized prostate cancer. Med Care 2011, 49:999-1006.
29. Ellis S.D., Blackard B., Carpenter W.R., et al. Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina. Cancer 2013, 119:2282-2290.
30. Elliott S.P., Johnson D.P., Jarosek S.L., Konety B.R., Adejoro O.O., Virnig B.A. Bias due to missing SEER data in D'Amico risk stratification of prostate cancer. J Urol 2012, 187:2026-2031.